The animal model market is projected to reach a value of US$ 1.7 Billion in 2022 and is anticipated to grow to US$ 2.9 Billion by 2032, showcasing a compound annual growth rate (CAGR) of 5.5% from 2022 to 2032.

The animal model market has witnessed significant growth and transformation in recent years, driven by the increasing demand for preclinical testing in pharmaceutical and biotechnological research. Animal models, including mice, rats, rabbits, and non-human primates, play a crucial role in understanding human physiology, studying diseases, and evaluating potential therapeutic interventions. This market has become an indispensable component of the drug development process, offering valuable insights before moving to human clinical trials.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=1590

Market Dynamics:

The animal model market is characterized by a complex interplay of factors that shape its trajectory. One key driver is the rising prevalence of chronic diseases, prompting intensified research efforts to discover novel treatments and therapeutic interventions. Additionally, advancements in genetic engineering technologies have fueled the demand for genetically modified (GM) animal models, enabling researchers to mimic specific human diseases with greater precision.

Government initiatives and funding support for biomedical research also contribute significantly to market growth. The continuous evolution of techniques such as CRISPR/Cas9 gene editing has further enhanced the creation of sophisticated animal models, making them more relevant and reliable for studying complex diseases.

However, ethical concerns and regulatory challenges associated with animal experimentation pose a substantial constraint to market expansion. Striking a balance between scientific progress and ethical considerations remains a critical challenge for stakeholders in the animal model market.

Market Future Outlook:

The future of the animal model market looks promising, with several trends shaping its trajectory. Personalized medicine is gaining prominence, and animal models are expected to play a crucial role in preclinical testing for tailored therapies. The integration of artificial intelligence and big data analytics into animal research is anticipated to enhance the efficiency of experiments, leading to more robust and reproducible results.

Furthermore, the increasing focus on developing alternative methods, such as in vitro and in silico models, is likely to impact the animal model market. These alternatives aim to reduce the reliance on animal experimentation, addressing ethical concerns and meeting evolving regulatory requirements.

As the pharmaceutical and biotechnology industries continue to expand, the demand for specialized animal models for drug development and toxicity testing is expected to rise. The emergence of advanced technologies, coupled with a growing emphasis on precision medicine, will drive innovation in the animal model market.

Market Insights:

The animal model market provides valuable insights into disease mechanisms, treatment efficacy, and safety profiles of new drugs. Mouse models, in particular, remain a cornerstone in preclinical research, owing to their genetic similarity to humans and the availability of a wide range of genetically modified strains. Rat models, zebrafish, and non-human primates also contribute significantly to diverse research areas.

In recent years, the COVID-19 pandemic has underscored the importance of animal models in studying infectious diseases and developing vaccines. This unprecedented global health crisis has further accelerated research efforts and collaboration within the animal model market.

Key Players:

  • Genoway SA
  • Eurofins Scientific SE
  • Crown Bioscience Inc.
  • Envigo CRS SA
  • Transposagen Biopharmaceuticals, Inc.
  • Trans Genic Inc.
  • The Jackson Laboratory
  • Horizon Discovery Group Plc.
  • Charles River Laboratories International Inc.

Competitive Landscape:

To enhance their market reach and solidify their position in the industry, prominent suppliers of animal model systems are actively pursuing strategic acquisitions, mergers, collaborations, and partnerships. The recent influx of investments from major corporations has presented lucrative prospects for the sector's global expansion. Noteworthy advancements include:

In April 2022, Taconic Biosciences and Biomodels joined forces to establish the Taconic-Biomodels Microbiome Initiative (TBMI). This initiative aims to provide researchers with seamless access to comprehensive solutions for germ-free and gnotobiotic microbiome studies, encompassing everything from study design to data analysis. By integrating access to relevant disease models, germ-free animal production, and in-vivo research design, execution, and analytics, TBMI eliminates longstanding obstacles that have hindered microbiome research.

In September 2021, Inotiv Inc. and Envigo announced a mutually beneficial agreement. Inotiv Inc. has agreed to acquire Envigo, enabling both companies to gain improved access to a wide range of products and services throughout the entire discovery and non-clinical development process. This acquisition consolidates their offerings within a single organization, fostering enhanced efficiency and effectiveness in their operations.

Key Segments Covered in the Animal Model Industry Report

  • Animal Model Market by Species :
    • Rat Models
    • Mice Models
    • Guinea Pig Models
    • Rabbit Models
    • Monkey Models
    • Dog Models
    • Pig Models
    • Cat Models
    • Other Animal Species Models
  • Animal Model by Application :
    • Animal Models for Basic & Applied Research
    • Animal Models for Drug Discovery/Development
  • Animal Model by End User :
    • Academic & Research Institutions
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Contract Research Organizations (Cros)
    • Other End Users
  • Animal Model by Region :
    • North America Animal Model Market
    • Latin America Animal Model Market
    • Europe Animal Model Market
    • South Korea Animal Model Market
    • APAC Animal Model Market
    • Middle East & Africa Animal Model Market

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=1590

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com